Viking Therapeutics (VKTX) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 26.09 -0.74 (2.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.83 | 52 Week High | $5.17 | |||
| Open | $26.88 | 52 Week Low | $0.94 | |||
| Day High | $27.58 | P/E | N/A | |||
| Day Low | $26.08 | EPS | $0.00 | |||
| Volume | 2,072,313 | |||||
